CBD patch for seizures in Dravet or Lennox-Gastaut
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study tests a new CBD patch placed on the skin to see if it can reduce seizures in people with Dravet syndrome or Lennox-Gastaut syndrome. The patch delivers CBD slowly over time, and the goal is to help control seizures that are not well managed by current medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 55 years old.
- You have been diagnosed with Dravet syndrome or Lennox-Gastaut syndrome by a doctor.
- You had at least 4 seizures in the last 28 days.
- You take at least one anti-seizure medication and are on a stable dose for at least 4 weeks.
- You are not using any cannabis or CBD products now and agree not to during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at switching children with Dravet or Lennox Gastaut syndrome from artisanal CBD products to a standardized FDA-approved CBD medication called Epidiolex, to see if it works as well or better for seizure control.
This study tests a new brain stimulation device that adjusts treatment based on your sleep patterns to reduce seizures in Lennox-Gastaut syndrome. The device may help people whose seizures haven't been controlled by medications alone.
This trial tests a new type of brain stimulation (adaptive deep brain stimulation) that adjusts in real time to stop seizures in children with Lennox-Gastaut syndrome. It's for children who haven't gotten enough help from medications and have frequent drop seizures.
This trial tests if using a small, at-home EEG patch can help doctors adjust the dose of fenfluramine more safely and effectively for people with Dravet syndrome or Lennox-Gastaut syndrome. You may be eligible if you are starting fenfluramine for the first time.
This study tests a gradual dose increase of CBD oil (Epidiolex) to see if it helps reduce seizures in adults with Lennox-Gastaut syndrome. It's for people who haven't tried CBD before or haven't used it in at least 3 months.
This trial tests if cannabinoids can help people who still have seizures despite trying two or more standard seizure medications. It aims to reduce seizure frequency in those with drug-resistant epilepsy.
Hear when a new Lennox Gastaut Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.